Moderna, Inc.MRNANASDAQ
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank31
Year-over-Year Change
Year-over-year research & development expense growth
Percentile
P31
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -3.25% |
| Q3 2025 | 14.43% |
| Q2 2025 | -18.22% |
| Q1 2025 | -23.71% |
| Q4 2024 | -1.32% |
| Q3 2024 | -6.88% |
| Q2 2024 | 18.89% |
| Q1 2024 | -26.96% |
| Q4 2023 | 21.21% |
| Q3 2023 | 1.05% |
| Q2 2023 | 1.50% |
| Q1 2023 | -6.61% |
| Q4 2022 | 47.68% |
| Q3 2022 | 15.49% |
| Q2 2022 | 28.16% |
| Q1 2022 | -14.51% |
| Q4 2021 | 24.38% |
| Q3 2021 | 23.75% |
| Q2 2021 | 4.99% |
| Q1 2021 | -47.16% |
| Q4 2020 | 120.29% |
| Q3 2020 | 126.85% |
| Q2 2020 | 31.89% |
| Q1 2020 | -2.03% |
| Q4 2019 | -1.83% |
| Q3 2019 | -6.83% |
| Q2 2019 | -1.59% |
| Q1 2019 | -13.20% |
| Q4 2018 | 37.94% |
| Q3 2018 | 4.38% |
| Q2 2018 | 15.93% |
| Q1 2018 | -23.51% |
| Q4 2017 | 25.87% |
| Q3 2017 | -5.93% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |